ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2439

A Brief Exercise and Self Management Programme Improves Upper Limb Disability in People with Early Rheumatoid Arthritis

Lindsay M. Bearne1, Victoria L. Manning2, David L. Scott3, Ernest Choy4 and Michael V. Hurley5, 1Academic Department of Physiotherapy, Health and Social Care Research Division,, Kings College London, London, United Kingdom, 2Academic Department of Physiotherapy, Health and Social Care Research Division, Kings College London, London, United Kingdom, 3King's College London, Department of Rheumatology, London, United Kingdom, 4Section of Rheumatology, Cardiff University School of Medicine, Cardiff, United Kingdom, 5School of Rehabilitation Sciences, St George's University of London and Kingston University, London, United Kingdom

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: clinical trials, exercise, physical therapy, rheumatoid arthritis (RA) and self-management

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Programs and Literacy in Patients with Rheumatologic Diseases

Session Type: Abstract Submissions (ARHP)

Background/Purpose:   Upper limb dysfunction occurs early in people with rheumatoid arthritis (RA) and deteriorates as the disease progresses, impacting on independence and work capacity. Exercise is a important component in the management of upper limb disability, however, studies focus on the hand in isolation and do not address potential proximal motor deficits. Individually tailored, home exercise regimens are required to address global upper limb dysfunction which, if completed in the long term, could encourage self management. This study evaluated the efficacy of a gobal, upper limb home exercise programme supplemented with a brief supervised exercise, education and self management (Education and eXercise Training in early Rheumatoid Arthritis (EXTRA)) programme.

Methods:  108 adults with RA of less than 5 years duration (26 males, age mean (SD) 55 (15) years, disease duration 20 (19) months) were randomized to receive either Usual Care (n= 52) or  the EXTRA programme (n=56). This progamme is a tailored home exercise regimen, focused on improving upper limb function, which is supplemented with 4 group supervised exercise, education and self management sessions, aimed at improving self efficacy and disease self management (2 sessions  per week for the first 2 weeks, each session lasting approximately 1 hour, with 4-6 participants per group). Upper limb disability (Disability of Arm, Shoulder, Hand questionnaire (DASH)), grip strength, function (Grip Ability Test (GAT)), self efficacy (Arthritis Self Efficacy Scale – pain subscale (PSE)) and disease activity (Disease Activity Score (DAS 28)) were assessed at baseline, 3 months (primary end point) and 9 months. Intention to treat analysis using full factorial mixed Analysis of Variance (ANOVA) (treatment, time and treatment x time interaction) adjusted for baseline disease duration, disease activity and disability, and  corrected for multiple comparisons, were used to determine between group differences,. Significance was accepted at P<0.05.

Results: Compared to a usual care control group, participants who completed the EXTRA programme demonstrated improved disability, function, non dominant grip strength and self efficacy with no adverse effects on disease activity (Table).

 

Table: Changes in disability, grip strength, function,  self efficacy  and disease activity following the EXTRA programme or Usual Care  

 Mean (95% Confidence intervals)

    EXTRA programme     Usual Care

  

 Between Group  Differences

   

 Effect size (95% CI)   (P value)

Disability  (DASH)

 
 

Baseline

44.6 (37.2,52.0) 40.8 (33.6,48.0) 3.8 (-6.6,14.1)
 
 
change at 3 months -5.3 (-10.4, -0.2)† 1.5 (-3.5, 6.5) -6.8 (-12.6,-1.0)†
 
0.5 (-2.3,3.3)               (0.022)†
change at 6 months -2.7(-9.5, 4.2) -1.4 (-8.0,5.3) -1.3 (-9.1,6.5)
 
0.1 (-3.7,3.9)               (0.730)
 
Dominant Grip Strength (N)
Baseline

 

183.3 (150.2,216.5)

 

220.5 (188.5,252.4)

 

-37.2 (-83.2, 8.9)

change at 3 months

 

23.1 (0.8,45.4)

 

0.3 (-21.2,21.8)

 

22.9 (-2.4,48.1)

 

0.35 (-12.0,12.7)          (0.140)

change at 6 months

 

16.0 (-14.3,46.2)

 

-3.0 (-32.1,26.2)

 

18.9 (-15.3,53.2)

 

0.21 (-16.5,17.0)          (0.480)

Non Dominant Grip strength (N)
Baseline

 

171.7 (139.9,203.6)

 

214.2 (183.5,244.9)

 

-42.5 (-86.7,1.8)

 
change at 3 months 17.5 (-1.9,36.9)†

 

-6.8 (-25.5,11.9)

24.3 (2.3,46.3)†

 

0.43 (-10.3,11.2)           (0.037)†

change at 6 months

 

6.1 (-22.7,34.9)

 

-8.4 (-36.1,19.4)

 

14.5 (-18.2,47.1)

 

0.17 (-15.8, 16.1)          (0.648)

 
Function (GAT seconds) 
Baseline

 

23.1 (19.3,26.8)

 

21.9 (18.3,25.5)

 

1.1 (-4.0,6.3)

change at 3 months -1.8 (-5.1,1.5)‡

 

1.5 (-1.6, 4.7)

-3.3 (-7.0,0.4)†

 

0.4 (-1.4,2.2)                (0.010)†

change at 6 months -0.8 (-4.7,3.0)‡

 

-0.5 (-4.2,3.2)

 

-0.4 (-4.7,4.0)

 

0.0 (-2.1,2.1)                (0.130)

 
Self efficacy (PSE)
Baseline

 

57.5 (50.7,64.2)

 

59.2 (52.9,65.6)

 

-1.7 (-11.0,7.5)

Change at 3 months

 

4.8 (-3.1,12.8)

 

-5.7 (-13.2,1.8)

10.5 (1.6,19.5)†

 

0.53 (-3.8,4.9)              (0.020)†

Change at 6 months

 

6.6 (-0.8,14.0)

 

-1.8 (-8.8,5.2)

8.4 (0.1,16.7)†

 

0.45 (-3.6,4.5)              (0.047)†

 
Disease Activity (DAS28)
Baseline 5.3 (4.7,5.9) 4.9 (4.4,5.5) 0.4 (-0.4,1.2)
change at 3months -0.8 (-1.4,-0.2)‡ -0.1 (-0.7,0.4) -0.7 (-1.4,0.0)† 0.55 (0.2,0.9)               (0.048)†
change at 6 months -0.8 (-1.4,-0.1)† -0.2 (-0.8,0.4) -0.5 (-1.2,0.1) 0.43 (0.1,0.8)                (0.120)
 
‡ P<0.01            † P0.05

Conclusion: The EXTRA programme improves upper limb disability, grip strength, self efficacy and function in people with early RA, with no detrimental effects on disease activity. This brief intervention may be easily implemented into clinical practice.


Disclosure:

L. M. Bearne,

Physiotherapy Research Foundation,

2;

V. L. Manning,

Physiotherapy Research Foundation,

2;

D. L. Scott,
None;

E. Choy,
None;

M. V. Hurley,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-brief-exercise-and-self-management-programme-improves-upper-limb-disability-in-people-with-early-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology